Skip to main content
Equasens logo

Equasens — Investor Relations & Filings

Ticker · EQS ISIN · FR0012882389 LEI · 96950066I7XVFGZI8L92 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 326 across all filing types
Latest filing 2019-07-03 Regulatory Filings
Country FR France
Listing PA EQS

About Equasens

https://equasens.com

Equasens is a company specializing in healthcare IT solutions for professionals and establishments. It develops and provides a range of products including professional software, electronic equipment, connected devices, and digital health solutions. The company's offerings cater to a diverse client base, including pharmacies, hospitals, nursing homes (EHPADs), home care services, and independent medical practitioners. The primary objective of its solutions is to improve the quality of patient care by facilitating the secure sharing of health data, enhancing communication between different care providers, and optimizing the coordination of care pathways across outpatient, hospital, and home care settings.

Recent filings

Filing Released Lang Actions
PHARMAGEST INTERACTIVE :
Regulatory Filings Classification · 1% confidence The document is a press release dated July 3, 2019, titled "BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE CONTRACTE AVEC LA SOCIETE DE BOURSE GILBERT DUPONT" (Semi-annual review of the liquidity contract with the stock brokerage firm Gilbert Dupont). It reports the status of the liquidity account (number of shares and cash balance) as of June 28, 2019, and compares it to the annual review from December 31, 2018. This type of announcement, detailing the status of a liquidity contract or share buyback/issuance program, most closely aligns with the 'Transaction in Own Shares' (POS) category, which covers share repurchase/issuance activities, or potentially 'Capital/Financing Update' (CAP). Given the specific focus on the liquidity contract balance, POS is the most precise fit, as liquidity contracts are mechanisms for managing share supply/demand. Since the document is a short press release announcing a periodic update rather than a comprehensive financial report, it is not an IR, 10-K, or AR. It is an announcement of a specific corporate action related to shares.
2019-07-03 French
PHARMAGEST INTERACTIVE : AGO du 27 juin 2019 - Avis de convocation
AGM Information Classification · 1% confidence The document is explicitly titled 'COMMUNIQUE DE PRESSE' and 'ASSEMBLEE GENERALE ORDINAIRE ANNUELLE' followed by 'Avis de convocation' (Notice of Meeting). It invites shareholders to the Annual General Meeting (AGM) on a specific date and location. This content directly relates to the materials shared for the AGM, fitting the definition of 'AGM Information'. Although it is a notice, the content is specific to the AGM proceedings rather than just announcing the publication of a report (which would suggest RPA or RNS). Given the specific focus on the AGM details, AGM-R is the most appropriate classification.
2019-06-12 French
Pharmagest Interactive: Annual General Meeting of June 27, 2019 - Notice of meeting
AGM Information Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and contains a "Notice" for the "ANNUAL ORDINARY GENERAL MEETING" (AGM) scheduled for June 27, 2019. It details the location, date, and mentions that the agenda and draft resolutions were previously published. This document serves as the formal notification or announcement regarding the upcoming AGM, rather than the presentation materials themselves (AGM-R) or the proxy solicitation materials (PSI). Since it is a notice/announcement about a specific corporate event (AGM), and the content is brief and focused on the logistics of the meeting, it aligns best with the general category for AGM-related announcements, which is AGM-R, although it is the notice *for* the meeting, not the materials *from* it. Given the options, AGM-R is the most specific fit for an AGM Notice, as it relates directly to the Annual General Meeting.
2019-06-12 English
Pharmagest Interactive: Annual Ordinary General Meeting - On-Line availability of Meeting Materials
AGM Information Classification · 1% confidence The document is a press release dated June 7, 2019, titled 'ANNUAL ORDINARY GENERAL MEETING ON JUNE, 27, 2019' and specifically announces the 'On-line Availability of Meeting Materials'. It details the date, time, and location of the upcoming Annual Ordinary General Meeting (AGM) and informs shareholders where the meeting materials (agenda, draft resolutions) can be accessed. Since the document is primarily focused on announcing the availability of materials for the AGM, it fits the description of an AGM-related announcement. While it mentions the materials are available, the core subject is the meeting itself and the associated logistics/documentation availability, making AGM-R the most appropriate fit over RPA, which is usually for the report itself being published. The document is short (3145 chars) and serves as a notice regarding the AGM.
2019-06-07 English
PHARMAGEST INTERACTIVE : AGO du 27 juin 2019 - Mise en ligne des documents préparatoires
AGM Information Classification · 1% confidence The document is explicitly titled 'COMMUNIQUE DE PRESSE' and announces the 'Mise en ligne des documents préparatoires' (Posting online of preparatory documents) for the 'ASSEMBLEE GENERALE ORDINAIRE ANNUELLE DU 27 JUIN 2019' (Annual General Meeting of June 27, 2019). It details when and where the preparatory materials (agenda, resolutions, voting forms) related to the AGM have been made available online. Since the document itself is an announcement about the availability of AGM materials rather than the AGM presentation itself or the voting results, it fits best under the category for announcements related to general meetings or regulatory filings. Given the specific focus on the AGM preparation documents being made available, 'AGM-R' (AGM Information) is a strong candidate, but the 'MENU VS MEAL' rule suggests that an announcement about documents being published often points to RPA or RNS. However, since the core subject is the AGM, and the document is essentially a notice regarding the AGM process and materials availability, 'AGM-R' is the most specific fit among the options that cover meeting-related content, even if it's a notice about the materials rather than the meeting itself. If 'AGM-R' is strictly for presentations, 'RPA' (Report Publication Announcement) would be the fallback for announcing the availability of documents. Given the context of 'Mise en ligne des documents préparatoires' for the AGM, 'AGM-R' captures the subject matter best, as these preparatory documents are central to the AGM process.
2019-06-07 French
PHARMAGEST INTERACTIVE : Finalisation de la prise de participation au capital de la société italienne Pharmathek
M&A Activity Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces the finalization of a capital participation/acquisition involving Pharmagest and Pharmathek. This type of announcement, detailing a significant corporate transaction (M&A activity), is best classified under the Merger & Acquisition Activity (TAR) category. Although it mentions the upcoming AGM and dividend proposal, the primary focus and substance of the press release is the strategic transaction. It is not a full 10-K, IR, or ER, nor is it a simple announcement of a report publication (RPA/RNS).
2019-06-05 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.